乳腺癌伴心包转移1例
A Case of Breast Cancer with Pericardial Me-tastasis
DOI: 10.12677/ACM.2023.1361438, PDF,    国家自然科学基金支持
作者: 郑士耀, 曹玉文, 王良海, 梁伟华, 杨 兰*:石河子大学医学院病理系,新疆 石河子;石河子大学第一附属医院病理科,新疆 石河子;孙 畅, 杨 铭, 苗婷婷, 胡浇浇:石河子大学医学院病理系,新疆 石河子 ;丛竹军:石河子大学第一附属医院胃肠乳腺外科,新疆 石河子 ;崔晓宾*:石河子大学医学院病理系,新疆 石河子;南京大学医学院附属鼓楼医院病理科,江苏 南京
关键词: 乳腺癌转移恶性心包积液Breast Cancer Metastasis Malignant Pericardial Effusion
摘要: 乳腺癌的心脏转移是一种已知但是少见的晚期恶性并发症,我们报道了一例乳腺癌转移产生恶性心包积液的病例,一位65岁的女性在接受左乳腺癌改良根治术后两年出现胸闷气憋等症状,行心包穿刺置管引流术后将心包积液送病理科行液体蜡块制作、免疫组织化学检测等技术,最后确诊为乳腺癌心包转移疾病,患者在恶性心包积液出现3个月后去世。因此,对有乳腺癌病史的心包积液患者,抽取心包积液送病理诊断对其治疗方案的制定和预后分析有重要意义。
Abstract: Cardiac metastasis from breast cancer is a known but rare late malignant complication. We report a case of breast cancer metastasis producing malignant pericardial effusion in a 65-year-old woman who developed chest tightness and breathlessness two years after undergoing modified radical surgery for left breast cancer, and the pericardial effusion was sent to the pathology department for liquid wax block production and immunohistochemical testing after pericardiocentesis and drain-age. The final diagnosis was metastatic breast cancer. The patient died 3 months after the appear-ance of the malignant pericardial effusion. Therefore, in patients with pericardial effusion with a history of breast cancer, the extraction of pericardial effusion for pathological diagnosis is important for the development of their treatment plan and prognostic analysis.
文章引用:郑士耀, 孙畅, 杨铭, 苗婷婷, 胡浇浇, 丛竹军, 曹玉文, 王良海, 梁伟华, 杨兰, 崔晓宾. 乳腺癌伴心包转移1例[J]. 临床医学进展, 2023, 13(6): 10275-10280. https://doi.org/10.12677/ACM.2023.1361438

参考文献

[1] Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. [Google Scholar] [CrossRef] [PubMed]
[2] Koo, J.S., Jung, W. and Jeong, J. (2010) Metastatic Breast Cancer Shows Different Immunohistochemical Phenotype According to Metastatic Site. Tumori Journal, 96, 424-432. [Google Scholar] [CrossRef] [PubMed]
[3] 丁乃晴. 癌性心包积液12例报告[J]. 山东医药, 1996(2): 52.
[4] Neves, M.B.M., Stival, M.V., Neves, Y.C.S., et al. (2021) Malignant Pericardial Effusion as a Primary Mani-festation of Metastatic Colon Cancer: A Case Report. Journal of Medical Case Reports, 15, Article No. 543. [Google Scholar] [CrossRef] [PubMed]
[5] Leja, M.J., Shah, D.J. and Reardon, M.J. (2011) Primary Car-diac Tumors. Texas Heart Institute Journal, 38, 261-262.
[6] Rebegea, L., Ilie, A.M., Paslaru, A.M., et al. (2021) Management of Epicardial Metastasis in Breast Cancer. Chirurgia (Bucur), 116, 627-633. [Google Scholar] [CrossRef] [PubMed]
[7] Riquet, M., Grand, B., Arame, A., et al. (2010) Lung Cancer In-vading the Pericardium: Quantum of Lymph Nodes. The Annals of Thoracic Surgery, 90, 1773-1777. [Google Scholar] [CrossRef] [PubMed]
[8] Jung, J.I., Kim, H.H., Park, S.H., et al. (2004) Thoracic Manifestations of Breast Cancer and Its Therapy. RadioGraphics, 24, 1269-1285. [Google Scholar] [CrossRef] [PubMed]
[9] Voigt, P., Wienbeck, S., Weber, M.A., et al. (2018) Cardiac Hemato-logical Malignancies: Typical Growth Patterns, Imaging Features, and Clinical Outcome. Angiology, 69, 170-176. [Google Scholar] [CrossRef] [PubMed]
[10] Silvestri, F., Bussani, R., Pavletic, N. and Mannone, T. (1997) Metastases of the Heart and Pericardium. Giornale Italiano di Cardiologia, 27, 1252-1255.
[11] 陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床, 2015, 12(13): 668-674.
[12] Miller, K.D., Siegel, R.L., Lin, C.C., et al. (2016) Cancer Treatment and Survivorship Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 271-289. [Google Scholar] [CrossRef] [PubMed]
[13] 艾勇彪, 黄军, 章书铭, 等. Luminal B型早期乳腺癌临床病理特点及预后危险因素分析[J]. 现代肿瘤医学, 2022, 30(7): 1214-1218.
[14] Takeuchi, H., Muto, Y. and Tashiro, H. (2009) Clinicopathological Characteristics of Recurrence More than 10 Years after Surgery in Patients with Breast Carcinoma. Anticancer Research, 29, 3445-3448.
[15] Lv, X., He, J., Shen, Y., et al. (2016) Malignant Pleural and Per-icardial Effusions and Meningeal Infiltrates without Other Metastases in Breast Cancer: A Case Report. Molecular and Clinical Oncology, 4, 855-858. [Google Scholar] [CrossRef] [PubMed]
[16] Chang, H.-M., Moudgil, R., Scarabelli, T., et al. (2017) Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention and Management—Part 1. Journal of the American College of Cardiology, 70, 2536-2551. [Google Scholar] [CrossRef] [PubMed]
[17] 王晗, 赵杰, 雷芹, 等. 细胞块石蜡包埋切片和细胞涂片鉴别诊断良、恶性胸腹腔积液的临床效果比较[J]. 昆明医科大学学报, 2016, 37(1): 77-80.
[18] Saab, J., Hoda, R.S., Narula, N., et al. (2017) Diagnostic Yield of Cytopathology in Evaluating Pericardial Effusions: Clinicopathologic Analysis of 419 Specimens. Cancer Cytopathology, 125, 128-137. [Google Scholar] [CrossRef] [PubMed]